NeuroOne Medical Technologies Corporation (NMTC)
NASDAQ: NMTC · Real-Time Price · USD
0.758
0.00 (0.03%)
Dec 20, 2024, 4:00 PM EST - Market closed
NMTC Income Statement
Financials in millions USD. Fiscal year is October - September.
Millions USD. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2019 - 2015 |
| Revenue | 3.45 | 3.45 | 3.41 | 2.12 | 0.24 | 1.93 | Upgrade
|
| Revenue Growth (YoY) | 1.33% | 1.33% | 60.73% | 772.60% | -87.39% | - | Upgrade
|
| Cost of Revenue | 7.44 | 7.44 | 8.44 | 5.17 | 4.2 | 2.08 | Upgrade
|
| Gross Profit | -3.99 | -3.99 | -5.03 | -3.05 | -3.96 | -0.15 | Upgrade
|
| Selling, General & Admin | 7.9 | 7.9 | 6.93 | 6.98 | 6.26 | 4.75 | Upgrade
|
| Operating Expenses | 7.9 | 7.9 | 6.93 | 6.98 | 6.26 | 4.75 | Upgrade
|
| Operating Income | -11.89 | -11.89 | -11.96 | -10.03 | -10.22 | -4.9 | Upgrade
|
| Interest Expense | -0.1 | -0.1 | - | - | -0 | -7.52 | Upgrade
|
| Interest & Investment Income | - | - | 0.2 | - | - | - | Upgrade
|
| Other Non Operating Income (Expenses) | -0.33 | -0.33 | -0.07 | 0.03 | -0.01 | 0.8 | Upgrade
|
| EBT Excluding Unusual Items | -12.32 | -12.32 | -11.83 | -10 | -10.23 | -11.62 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | -0.03 | - | - | - | Upgrade
|
| Legal Settlements | - | - | - | - | 0.2 | - | Upgrade
|
| Other Unusual Items | - | - | - | - | 0.08 | -2.02 | Upgrade
|
| Pretax Income | -12.32 | -12.32 | -11.86 | -10 | -9.95 | -13.64 | Upgrade
|
| Net Income | -12.32 | -12.32 | -11.86 | -10 | -9.95 | -13.64 | Upgrade
|
| Net Income to Common | -12.32 | -12.32 | -11.86 | -10 | -9.95 | -13.64 | Upgrade
|
| Shares Outstanding (Basic) | 27 | 27 | 18 | 16 | 11 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 27 | 27 | 18 | 16 | 11 | 5 | Upgrade
|
| Shares Change (YoY) | 47.69% | 47.69% | 13.27% | 49.56% | 97.52% | 37.01% | Upgrade
|
| EPS (Basic) | -0.46 | -0.46 | -0.65 | -0.63 | -0.93 | -2.52 | Upgrade
|
| EPS (Diluted) | -0.46 | -0.46 | -0.65 | -0.63 | -0.93 | -2.52 | Upgrade
|
| Free Cash Flow | -11.13 | -11.13 | -13.27 | -7.79 | -8.67 | -3.55 | Upgrade
|
| Free Cash Flow Per Share | -0.42 | -0.42 | -0.73 | -0.49 | -0.81 | -0.66 | Upgrade
|
| Gross Margin | -115.42% | -115.42% | -147.58% | -143.93% | - | -7.75% | Upgrade
|
| Operating Margin | -344.26% | -344.26% | -350.84% | -473.14% | -4205.75% | -254.46% | Upgrade
|
| Profit Margin | -356.74% | -356.74% | -348.03% | -471.67% | -4094.60% | -708.00% | Upgrade
|
| Free Cash Flow Margin | -322.39% | -322.39% | -389.45% | -367.67% | -3568.48% | -184.15% | Upgrade
|
| EBITDA | -11.64 | -11.64 | -11.76 | -9.91 | -10.14 | -4.85 | Upgrade
|
| EBITDA Margin | - | - | - | - | - | -251.98% | Upgrade
|
| D&A For EBITDA | 0.25 | 0.25 | 0.2 | 0.12 | 0.08 | 0.05 | Upgrade
|
| EBIT | -11.89 | -11.89 | -11.96 | -10.03 | -10.22 | -4.9 | Upgrade
|
| EBIT Margin | - | - | - | - | - | -254.46% | Upgrade
|
| Advertising Expenses | 0.11 | 0.11 | 0.17 | 0.27 | 0.34 | - | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.